Volitionrx (VNRX) Return on Capital Employed (2019 - 2025)
Volitionrx (VNRX) has disclosed Return on Capital Employed for 8 consecutive years, with 5.9% as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Return on Capital Employed rose 418.0% year-over-year to 5.9%, compared with a TTM value of 5.9% through Sep 2025, up 418.0%, and an annual FY2024 reading of 2.48%, up 6.0% over the prior year.
- Return on Capital Employed was 5.9% for Q3 2025 at Volitionrx, down from 37.34% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 37.34% in Q2 2025 and bottomed at 35.59% in Q1 2023.
- Average Return on Capital Employed over 5 years is 3.95%, with a median of 2.56% recorded in 2023.
- The sharpest move saw Return on Capital Employed skyrocketed 4012bps in 2024, then plummeted -3972bps in 2025.
- Year by year, Return on Capital Employed stood at 1.27% in 2021, then crashed by -627bps to 9.26% in 2022, then surged by 72bps to 2.56% in 2023, then plummeted by -225bps to 8.32% in 2024, then soared by 171bps to 5.9% in 2025.
- Business Quant data shows Return on Capital Employed for VNRX at 5.9% in Q3 2025, 37.34% in Q2 2025, and 35.19% in Q1 2025.